Cell surface receptors are the root cause of a number of illnesses, and the target for most drugs on the market. But there’s still much to be discovered. At IPI, research into the conformational states of the opioid receptor — a G protein-coupled receptor that acts as gatekeeper of the pain signaling pathway — may someday lead to less addictive painkillers.
